Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31:205–12.
Article
CAS
PubMed
Google Scholar
Elder JT, Bruce AT, Gudjonsson JE, et al. Molecular dissection of psoriasis: integrating genetics and biology. J Investig Dermatol. 2010;130:1213–26.
Article
CAS
PubMed
Google Scholar
Melero JL, Andrades S, Arola L, Romeu A. Deciphering psoriasis. A bioinformatics approach. J Dermatol Sci. 2018;89(2):120–6.
Article
CAS
PubMed
Google Scholar
Della Valle V, Maggioni M, Carrera C, Cattaneo A, Marzano AV, Damiani G. A mysterious abdominal pain during active psoriasis. Intern Emerg Med. 2018;13(6):889–92.
Article
PubMed
Google Scholar
Damiani G, Franchi C, Pigatto P, Altomare A, Pacifico A, Petrou S, Leone S, Pace MC, Fiore M. Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents. World J Hepatol. 2018;10(2):329–36.
Article
PubMed
PubMed Central
Google Scholar
Fiore M, Leone S, Maraolo AE, Berti E, Damiani G. Liver illness and psoriatic patients. Biomed Res Int. 2018;2018:3140983.
Article
PubMed
PubMed Central
CAS
Google Scholar
Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2(3):161–76.
Article
Google Scholar
Xiang M, Guo L, Ma Y, Li Y. Expression of Th17 and CD4+ CD25+ T regulatory cells in peripheral blood of acute leukemia patients and their prognostic significance. Pak J Pharm Sci. 2017;30(2(Suppl.)):619–624.
Wang JM, Ma CJ, Li GY, Wu XY, Thayer P, Greer P, Smith AM, High KP, Moorman JP, Yao ZQ. Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection. Vaccine. 2013;31(18):2238–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bruno R, Sacchi P, Puoti M, Maiocchi L, Patruno SF, Cima S, Filice G. Pathogenesis of liver damage in HCV-HIV patients. AIDS Rev. 2008;10(1):15–24.
PubMed
Google Scholar
Chun K, Afshar M, Audish D, Kabigting F, Paik A, Gallo R, Hata T. Hepatitis C may enhance key amplifiers of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(4):672–8.
Article
CAS
PubMed
Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283 (15):2008–2012.
Wells G SB, O’Connell J, Robertson J, et al. The Newcastle- Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. 2011. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
Review Manager (RevMan) Computer program.. Version 5.3. Copenhagen: the nordic cochrane centre, The Cochrane Collaboration. 2014.
Piñero J, Ramírez-Anguita JM, Saüch-Pitarch J, Ronzano F, Centeno E, Sanz F, Furlong LI. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2020;48(D1):D845–55.
PubMed
Google Scholar
Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, Kuhn M, Bork P, Jensen LJ, von Mering C. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447–52.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8 Suppl 4(Suppl 4):S11.
Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999;27(1):29–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57.
Article
CAS
Google Scholar
Chouela E, Abeldaño A, Panetta J, Ducard M, Neglia V, Sookoian S, Kina M, Castaño G, Vereytou F, Frider B. Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis. Int J Dermatol. 1996;35(11):797–9.
Article
CAS
PubMed
Google Scholar
Palazzi C, Olivieri I, D’Amico E, D’Agostino L, Nicolucci A, Pennese E, Petricca A. Hepatitis C virus infection in psoriatic arthritis. Arthritis Rheum. 2005;53(2):223–5.
Article
PubMed
Google Scholar
Cohen AD, Weitzman D, Birkenfeld S, Dreiher J. Psoriasis associated with hepatitis C but not with hepatitis B. Dermatology. 2010;220(3):218–22.
Article
PubMed
Google Scholar
Tsai TF, Wang TS, Hung ST, Tsai PI, Schenkel B, Zhang M, Tang CH. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci. 2011;63(1):40–6.
Article
PubMed
Google Scholar
Andrade DL, de Oliveira Mde F, de Souza TF, Lima RA, Bomfim EA, Rêgo VR, Paraná R, Schinoni MI. Estudio sobre la infección por el virus de la hepatitis C en pacientes con psoriasis de un centro de referencia de Brasil A study about hepatitis C virus infection in patients with psoriasis in a Brazilian reference center.. Acta Gastroenterol Latinoam. 2012;42(4):285–90. Spanish.
Kanada KN, Schupp CW, Armstrong AW. Association between psoriasis and viral infections in the United States: focusing on hepatitis B, hepatitis C and human immunodeficiency virus. J Eur Acad Dermatol Venereol. 2013;27(10):1312–6.
CAS
PubMed
Google Scholar
Brazzelli V, Carugno A, Alborghetti A, Cananzi R, Sangiovanni L, Barbarini G, De Silvestri A, Borroni RG. Hepatitis C infection in Italian psoriatic patients: prevalence and correlation with patient age and psoriasis severity. J Eur Acad Dermatol Venereol. 2012;26(12):1581–2.
CAS
PubMed
Google Scholar
Imafuku S, Naito R, Nakayama J. Possible association of hepatitis C virus infection with late-onset psoriasis: a hospital-based observational study. J Dermatol. 2013;40(10):813–8.
CAS
PubMed
Google Scholar
Youssef R, Abu-Zeid O, Sayed K, Osman S, Omran D, El Shafei A, Ghaith D. Hepatitis C infection in Egyptian psoriatic patients: prevalence and correlation with severity of disease. Iran J Public Health. 2015;44(9):1294–5.
PubMed
PubMed Central
Google Scholar
Orrell KA, Vakharia PP, Hagstrom EL, Brieva J, West DP, Nardone B. Prevalence of chronic hepatitis B and C in psoriasis patients: a cross-sectional study in a large US population. J Am Acad Dermatol. 2017;77(3):572–3.
Article
PubMed
Google Scholar
Noe MH, Grewal SK, Shin DB, Ogdie A, Takeshita J, Gelfand JM. Increased prevalence of HCV and hepatic decompensation in adults with psoriasis: a population-based study in the United Kingdom. J Eur Acad Dermatol Venereol. 2017;31(10):1674–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Martins AM, Ascenso A, Ribeiro HM, Marto J. The Brain–skin connection and the pathogenesis of psoriasis: a review with a focus on the serotonergic system. Cells. 2020;9(4):796.
Article
CAS
PubMed Central
Google Scholar
Sevastianos VA, Voulgaris TA, Dourakis SP. Hepatitis C, systemic inflammation and oxidative stress: correlations with metabolic diseases. Expert Rev Gastroenterol Hepatol. 2020;14(1):27–37.
Article
CAS
PubMed
Google Scholar
Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017;140(3):645–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lowes MA, Russell CB, Martin DA, Towne JE, Krueger JG. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol. 2013;34(4):174–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, Agerberth B, Gudmundsson GH, Gallo RL. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Investig Dermatol. 2001;117(1):91–7.
Article
CAS
PubMed
Google Scholar
Ferrari SM, Ruffilli I, Colaci M, Antonelli A, Ferri C, Fallahi P. CXCL10 in psoriasis. Adv Med Sci. 2015;60(2):349–54.
Article
PubMed
Google Scholar
Goebeler M, Toksoy A, Spandau U, Engelhardt E, Bröcker EB, Gillitzer R. The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions. J Pathol. 1998;184(1):89–95.
Article
CAS
PubMed
Google Scholar
Guttman-Yassky E, Krueger JG. IL-17C: a unique epithelial cytokine with potential for targeting across the spectrum of atopic dermatitis and psoriasis. J Investig Dermatol. 2018;138(7):1467–9.
Article
CAS
PubMed
Google Scholar
Johnston A, Xing X, Guzman AM, Riblett M, Loyd CM, Ward NL, Wohn C, Prens EP, Wang F, Maier LE, Kang S, Voorhees JJ, Elder JT, Gudjonsson JE. IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol. 2011;186(4):2613–22.
Article
CAS
PubMed
Google Scholar
Johnston A, Xing X, Wolterink L, Barnes DH, Yin Z, Reingold L, Kahlenberg JM, Harms PW, Gudjonsson JE. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol. 2017;140(1):109–20.
Article
CAS
PubMed
Google Scholar
Li H, Li H, Huo R, Wu P, Shen Z, Xu H, Shen B, Li N. Cyr61/CCN1 induces CCL20 production by keratinocyte via activating p38 and JNK/AP-1 pathway in psoriasis. J Dermatol Sci. 2017;88(1):46–56.
Article
CAS
PubMed
Google Scholar
Saggini A, Chimenti S, Chiricozzi A. IL-6 as a druggable target in psoriasis: focus on pustular variants. J Immunol Res. 2014;2014:964069.
Zhang LJ, Sen GL, Ward NL, Johnston A, Chun K, Chen Y, Adase C, Sanford JA, Gao N, Chensee M, Sato E, Fritz Y, Baliwag J, Williams MR, Hata T, Gallo RL. Antimicrobial peptide LL37 and MAVS signaling drive interferon-β production by epidermal keratinocytes during skin injury. Immunity. 2016;45(1):119–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bader El Din NG, Farouk S, El-Shenawy R, Ibrahim MK, Dawood RM, Elhady MM, Salem AM, Zayed N, Khairy A, El Awady MK. Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients. World J Gastroenterol. 2016;22(34):7767–77.
Dostert C, Grusdat M, Letellier E, Brenner D. The TNF family of ligands and receptors: communication modules in the immune system and beyond. Physiol Rev. 2019;99(1):115–60.
Article
CAS
PubMed
Google Scholar
Dawood RM, Salum GM, Abd El-Meguid M, Shemis M, Abdel Aziz AO, El Awady MK. Recipient interleukin 6 gene polymorphism and expression predict HCV recurrence post liver transplantation. Gene. 2020;754:144887.
Piaserico S, Messina F, Russo FP. Managing psoriasis in patients with HBV or HCV infection: practical considerations. Am J Clin Dermatol. 2019;20(6):829–45.
Article
PubMed
Google Scholar
Furst DE, Keystone EC, Kirkham B, et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008. Ann Rheum Dis. 2008;67(Suppl. 3):iii2–25.
Ding T, Ledingham J, Luqmani R, et al. BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies. Rheumatology(Oxford). 2010;49:2217–9.
Rock FL, Hardiman G, Timans JC, et al. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA. 1998;95:588–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bureau C, Bernad J, Chaouche N, et al. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem. 2001;276:23077–83.
Article
CAS
PubMed
Google Scholar
Kawai T, Akira S. TLR signalling. Cell Death Differ. 2006;13:816–25.
Article
CAS
PubMed
Google Scholar
Kawai T, Akira S. Toll-like receptor downstream signalling. Arthritis Res Ther. 2005;7:12–9.
Article
CAS
PubMed
Google Scholar
Dolganiuc A, Kodys K, Marshall C, et al. Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells. PLoS One 2012;7:e44915.
Wang JP, Zhang Y, Wei X, et al. Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C. APMIS. 2010;118:261–70.
Article
CAS
PubMed
Google Scholar
Liang Y, Cao X, Ding Q, Zhao Y, He Z, Zhong J. Hepatitis C virus NS4B induces the degradation of TRIF to inhibit TLR3-mediated interferon signaling pathway. PLoS Pathog. 2018;14(5):e1007075.
Manzoor S, Khalil S, Malik MA, Shafique K, Gul S, Javed F. Induction of profibrotic microenvironment via TLR4 MyD88-dependent and -independent inflammatory signaling in chronic hepatitis C virus infection. Viral Immunol. 2020;33(9):585–93.
Article
CAS
PubMed
Google Scholar
Garcia-Rodriguez S, Arias-Santiago S, Perandrés-López R, Castellote L, Zumaquero E, Navarro P, Buendía-Eisman A, Ruiz JC, Orgaz-Molina J, Sancho J, M Zubiaur. Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis. J Eur Acad Dermatol Venereol. 2013;27(2):242–50.
Carrasco S, Neves FS, Fonseca MH, Gonçalves CR, Saad CG, Sampaio-Barros PD, Goldenstein-Schainberg C. Toll-like receptor (TLR) 2 is upregulated on peripheral blood monocytes of patients with psoriatic arthritis: a role for a gram-positive inflammatory trigger? Clin Exp Rheumatol. 2011;29(6):958–62.
PubMed
Google Scholar
Smith RL, Hébert HL, Massey J, et al. Association of toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis. Arch Dermatol Res. 2016;308(3):201–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shao S, Fang H, Dang E, Xue K, Zhang J, Li B, Qiao H, Cao T, Zhuang Y, Shen S, Zhang T, Qiao P, Li C, Gudjonsson JE, Wang G. Neutrophil extracellular traps promote inflammatory responses in psoriasis via activating epidermal TLR4/IL-36R crosstalk. Front Immunol. 2019;10:746.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schröfelbauer B, Raffetseder J, Hauner M, Wolkerstorfer A, Ernst W, Szolar OH. Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signalling published correction appears in Biochem J. 2009;422(3):571. Biochem J. 2009;421(3):473–482.
Yu JJ, Zhang CS, Coyle ME, et al. Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials. Curr Med Res Opin. 2017;33(2):279–87.
Article
CAS
PubMed
Google Scholar
Ashfaq UA, Masoud MS, Nawaz Z, Riazuddin S. Glycyrrhizin as antiviral agent against Hepatitis C Virus. J Transl Med. 2011;9:112.
Article
CAS
PubMed
PubMed Central
Google Scholar
GA Sun ZG, Zhao TT, Lu N, Yang YA, Zhu HL. Research Progress of Glycyrrhizic Acid on Antiviral Activity. Mini Rev Med Chem. 2019;19(10):826–832.